IVIG Prophylaxis in Myeloma Cuts Infections, Ups Survival
SAN DIEGO-- Patients with numerous myeloma who get intravenous immunoglobulin (IVIG) prophylaxis throughout treatment with teclistamab have less infections and much better total survival compared to those who do not get IVIG prophylaxis, according to brand-new findings provided here at the American Society of Hematology (ASH) 2024 Annual Meeting.Amongst 225 successive clients who got a minimum of one treatment for fallen back and/or refractory numerous myeloma, those who got IVIG prophylaxis experienced a considerably longer period of infection-free survival and a nearly threefold longer mean total survival compared to clients who did not get IVIG prophylaxis.IVIG supplements has actually been revealed to avoid serious infections in clients with numerous myeloma, however proof on the very ...